Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy and the breast.

J M Dixon1

  • 1Academic Office, Edinburgh Breast Unit, Western General Hospital, Scotland EH4 2XU, UK. jmd@wght.demon.ac.uk

Surgical Oncology
|March 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opportunities to expand delivery of prehospital tranexamic acid to bleeding trauma patients - findings from a prospective multicentre trauma study in the Western Cape Province, South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same author

Corrigendum to "Postmastectomy radiotherapy for all node positive patients: The case against" [Euro J Surg Oncol 47/10 (2021) 2515-2520].

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2021
Same author

Postmastectomy radiotherapy for all node positive patients: The case against.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2021
Same author

The value of 3D images in the aesthetic evaluation of breast cancer conservative treatment. Results from a prospective multicentric clinical trial.

Breast (Edinburgh, Scotland)·2018
Same author

Autologous breast reconstruction using the immediately lipofilled extended latissimus dorsi flap.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2017
Same author

European interpretation of North American post mastectomy radiotherapy guideline update.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017

Hormone replacement therapy (HRT) increases breast cancer risk and reduces screening effectiveness. While HRT use is linked to higher breast cancer mortality with longer duration, alternatives exist for menopausal symptom management.

Area of Science:

  • Oncology
  • Endocrinology
  • Radiology

Background:

  • Increasing use of hormone replacement therapy (HRT) in postmenopausal women.
  • HRT impacts breast density, potentially reducing mammography sensitivity and specificity.
  • HRT is associated with an increased risk of developing breast cancer.

Purpose of the Study:

  • To review the impact of HRT on breast density, screening, and breast cancer risk.
  • To evaluate the relationship between HRT duration and breast cancer risk and mortality.
  • To explore alternative treatments for menopausal symptoms, especially in breast cancer survivors.

Main Methods:

  • Literature review of studies on HRT and breast cancer.
  • Analysis of data on breast density changes, screening effectiveness, and cancer risk.

Related Experiment Videos

  • Evaluation of breast cancer mortality data in relation to HRT use.
  • Review of non-oestrogenic agents and Tibolone for menopausal symptom management.

    • Main Results:

    • HRT, particularly combined estrogen and progestogen, increases breast density and breast cancer risk.
    • Longer HRT use correlates with higher breast cancer risk and potentially increased mortality.
    • Current data on HRT use in breast cancer survivors is reassuring but limited.
    • Non-hormonal therapies and Tibolone are being evaluated as safer alternatives.

    Conclusions:

    • HRT demonstrably increases breast cancer risk, with combined therapies posing a greater risk.
    • Physicians must balance managing menopausal symptoms with the risks associated with HRT.
    • Alternative treatments are crucial for breast cancer survivors experiencing menopausal symptoms.